Rituximab yielded long-term benefit in lupus nephritis

PARIS – Treatment with rituximab in patients with refractory lupus nephritis was associated with significant long-term improvement in symptoms, histology, and laboratory markers in a prospective...

Field of Interest: Rheumatology
Type: News Item

Trial of sirukumab for lupus nephritis falls flat

PARIS – The investigational interleukin-6 blocker sirukumab provided no benefit to patients with lupus nephritis but put them at a very high risk of developing a serious infection in a small,...

Field of Interest: Rheumatology
Type: News Item

Real-world use supports belimumab clinical trial data

PARIS – Belimumab produced significant clinical improvement in 74% of patients with systemic lupus erythematosus who took it over a 6-month period, reducing disease symptoms and steroid use and...

Field of Interest: Rheumatology
Type: News Item

Monitor elderly for bone loss after gastric bypass

CHICAGO – Older adults who undergo Roux-en-Y gastric bypass are at risk for lessened bone mineral density for at least 2 years after their surgery and should be monitored appropriately for...

Field of Interest: Gastroentero...
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness